Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study

NCT: NCT03391323 · COMPLETED

NCT IDNCT03391323
StatusCOMPLETED
Start Date2015-04
Completion2023-11-27

Brief Summary

The study is a prospective, randomized comparison of total knee arthroplasty with the Medacta GMK Sphere® knee compared to the Medacta GMK PS knee, with comparison to data from previous trials of similar study design.

Frequently Asked Questions

What is Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study?

Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study is a clinical trial registered under NCT03391323. Current status: COMPLETED.

What is the status of NCT03391323?

The current status of NCT03391323 (Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study) is: COMPLETED.

When did Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study start?

Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study started on 2015-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑